Nanna Reiter
- Infectious Diseases top 10%
- Epidemiology
- Cell Biology
- Applied Microbiology and Biotechnology top 5%
- Clinical Biochemistry
- Co-authors
- Maiken Cavling ArendrupGuillermo García‐EffrónBrita BruunAnders PernerCornelia Lass‐FlörlDavid S. PerlinWalter BuzinaKlaus Leth Mortensen
- Topics
- Sepsis Diagnosis and Treatment (5 papers)Poisoning and overdose treatments (3 papers)Antifungal resistance and susceptibility (3 papers)
- Partner nations
- DenmarkUnited StatesSpain
In The Last Decade
Nanna Reiter
16 papers receiving 257 citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 169
- Epidemiology 137
- Cell Biology 33
- Applied Microbiology and Biotechnology 33
- Clinical Biochemistry 23
Countries citing papers authored by Nanna Reiter
This map shows the geographic impact of Nanna Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanna Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanna Reiter more than expected).
Fields of papers citing papers by Nanna Reiter
This network shows the impact of papers produced by Nanna Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanna Reiter. The network helps show where Nanna Reiter may publish in the future.
Co-authorship network of co-authors of Nanna Reiter
This figure shows the co-authorship network connecting the top 25 collaborators of Nanna Reiter. A scholar is included among the top collaborators of Nanna Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanna Reiter. Nanna Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | No reduction in mortality after centralisation in treatment of patients with ruptured abdominal aneurism. | 0 |
| 9 | 43 | |
| 10 | 14 | |
| 11 | [Disease burden and definition of sepsis in adults]. | 3 |
| 12 | Sygdomsbyrde og definitioner af sepsis hos voksne | 2 |
| 13 | 34 | |
| 14 | 18 | |
| 15 | The majority of patients in septic shock are transfused with fresh-frozen plasma. | 10 |
| 16 | 104 | |
| 17 | 18 | |
| 18 | [Vitamin E and excessive bleeding]. | 1 |
| 19 | [A case of pericarditis in a patient with brucellosis]. | 1 |
About Nanna Reiter
Nanna Reiter is a scholar working on Applied Microbiology and Biotechnology, Toxicology and Critical Care and Intensive Care Medicine, having authored 19 papers that have together received 259 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (5 papers), Poisoning and overdose treatments (3 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (33 citations), Infectious Diseases (169 citations) and Epidemiology (137 citations). Nanna Reiter has collaborated with scholars based in Denmark, United States and Spain. Frequent co-authors include Maiken Cavling Arendrup, Guillermo García‐Effrón, Brita Bruun, Anders Perner, Cornelia Lass‐Flörl, David S. Perlin, Walter Buzina, Klaus Leth Mortensen, Henrik Elvang Jensen and Jens Schierbeck. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Critical Care and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.